Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers. 2002

Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
Laboratoire de Pharmacologie Expérimentale et Clinique, Université de Rennes I - Faculté de Médecine, CS 34317, 35 043 Rennes cedex, France.

Piribedil is a dopamine agonist acting on D2 and D3 central nervous system dopamine receptors. This drug has been administered to 12 young healthy male volunteers (age 22 +/- 2 years) according to a single center randomized, double-blind, two ways cross-over, placebo controlled trial, including a washout period of one week. Placebo and piribedil were administered by a single intravenous infusion over 2 h (3 mg). Psychomotor performance and cognitive functions were assessed through a standardized and computerized psychometric tests battery and a continuous electroencephalogram (EEG) mapping. Piribedil improved simple reaction time (P=0.02), immediate (P=0.045 and 0.004), and delayed free recall (P=0.05), dual coding test (P=0.02) and increased theta and fast beta waves on the EEG (P < 0.05 and 0.001, respectively). No deleterious effect was observed on the tests exploring attention and concentration via the other procedures. It is concluded that a single intravenous perfusion of piribedil 3 mg improves alertness and the information processing speed within the central nervous system, in healthy volunteers.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D008606 Mental Processes Conceptual functions or thinking in all its forms. Information Processing, Human,Human Information Processing
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010891 Piribedil A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist. Piribendyl,ET-495,EU-4200,Piribedil Hydrochloride,Piribedil Mesylate,Piribedil Mono-hydrochloride,Trivastal,ET 495,ET495,EU 4200,EU4200,Hydrochloride, Piribedil,Mesylate, Piribedil,Mono-hydrochloride, Piribedil,Piribedil Mono hydrochloride
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D011939 Mental Recall The process whereby a representation of past experience is elicited. Recall, Mental

Related Publications

Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
December 1974, Clinical pharmacology and therapeutics,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
October 1989, Pharmacology & toxicology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
January 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
September 2009, Psychopharmacology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
January 1986, Clinical neuropharmacology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
March 2000, Human psychopharmacology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
August 1995, British journal of clinical pharmacology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
November 1997, Behavioural pharmacology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
August 2009, Human psychopharmacology,
Stéphane Schück, and Danièle Bentué-Ferrer, and Diane Kleinermans, and Jean-Michel Reymann, and Elisabeth Polard, and Jean-Marc Gandon, and Hervé Allain
October 1995, Vision research,
Copied contents to your clipboard!